A proposed US-UK drug deal may have significant consequences for healthcare in England, with some analyses suggesting it could result in a large number of excess deaths, potentially around 229,000. However, the exact number of deaths is uncertain, with one report estimating 220,000 avoidable deaths. The deal has sparked concerns among some groups, including a doctors' union, which warns that it could divert a substantial amount of funding from essential NHS services.